Related content

Inhibition of phosphatidylinositol 3-kinase

By Zahradka P.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 97-99

Informa Healthcare

Access to resources Recommend Favorite

The phosphatidylinositol 3-kinase inhibitor wortmannin markedly reduces chemotactic peptide-induced locomotion and increases in cytoskeletal actin in human neutrophils

By Niggli V.   Keller H.  

European Journal of Pharmacology, Vol. 335, Iss. 1, 1997-09 ,pp. : 43-52

Elsevier

Access to resources Recommend Favorite

Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats

By Tyagi Sandeep   Sharma Saurabh   Budhiraja Ramji Dass  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 7, 2012-07 ,pp. : 881-885

NRC Research Press

Access to resources Recommend Favorite

Halenaquinone, a novel phosphatidylinositol 3-kinase inhibitor from a marine sponge, induces apoptosis in PC12 cells

By Fujiwara H.   Matsunaga K.   Saito M.   Hagiya S.   Furukawa  

European Journal of Pharmacology, Vol. 413, Iss. 1, 2001-02 ,pp. : 37-45

Elsevier

Access to resources Recommend Favorite

CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies

By Castillo Jorge J   Furman Michael   Winer Eric S  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 1, 2012-01 ,pp. : 15-22

Informa Healthcare

Access to resources Recommend Favorite